Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Debra Rembert
Observed names:
D Rembert,
D. Rembert
Institutions:
McKesson (United States),
The US Oncology Network
Observed institutions:
McKesson (United States),
Milwaukee Health Department,
The US Oncology Network
OpenAlex ID:
A5006351491
Unsuspected Recent Transmission of Tuberculosis among High-Risk Groups: Implications of Universal Tuberculosis Genotyping in Its Detection
2005
·
N. Malakmadze
, I. M. Gonzalez
, et al.
·
Clinical Infectious Diseases
·
56
Sequencing of Cabazitaxel and Abiraterone Acetate After Docetaxel in Metastatic Castration-Resistant Prostate Cancer: Treatment Patterns and Clinical Outcomes in Multicenter Community-Based US Oncology Practices
2015
·
Guru Sonpavde
, Menaka Bhor
, et al.
·
Clinical Genitourinary Cancer
·
52
PDF
First-Line and Sequential Use of Pazopanib Followed by Mammalian Target of Rapamycin Inhibitor Therapy Among Patients With Advanced Renal Cell Carcinoma in a US Community Oncology Setting
2014
·
Nicholas J. Vogelzang
, Michelle D. Hackshaw
, et al.
·
Clinical Genitourinary Cancer
·
29
The Effectiveness of Tyrosine Kinase Inhibitors and Molecular Monitoring Patterns in Newly Diagnosed Patients With Chronic Myeloid Leukemia in the Community Setting
2015
·
Nicholas J. Di Bella
, Debajyoti Bhowmik
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
25
Treatment outcomes, health-care resource utilization and costs of bortezomib and dexamethasone, with cyclophosphamide or lenalidomide, in newly diagnosed multiple myeloma
2015
·
S K Kumar
, E Ma
, et al.
·
Leukemia
·
16
Economic impact of disease progression following front-line therapy in classical Hodgkin lymphoma
2015
·
Christopher A. Yasenchak
, Wan-Yu Tseng
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
16
A Real-World Observational Study of Patients with Advanced Melanoma Receiving First-Line Ipilimumab in a Community Practice Setting
2014
·
Debra A. Patt
, Debra Rembert
, et al.
·
Journal of Cancer Therapy
·
6
PDF
Impact Of Route Of Bortezomib (B) Administration On Dose Intensity and Time To Dose Reduction In Previously Untreated Patients (Pts) With Multiple Myeloma (MM)
2013
·
Robert M Rifkin
, Clara Chen
, et al.
·
Blood
·
3
Treatment response monitoring in chronic phase CML (CP-CML) patients receiving tyrosine kinase inhibitor (TKI) therapy in US Oncology network.
2013
·
Kathryn S. Kolibaba
, Hsing-wen Chung
, et al.
·
Journal of Clinical Oncology
·
3
Association Between Treatment Adherence and Response Among Patients With Chronic Myeloid Leukemia (CML) Receiving First-Line TKIs In The Community Setting
2013
·
Nicholas J. Di Bella
, Debajyoti Bhowmik
, et al.
·
Blood
·
2
Treatment of metastatic breast cancer with nab-paclitaxel in the community practice setting: a US oncology survey
2015
·
Debra Patt
, Debra Rembert
, et al.
·
The Journal of Community and Supportive Oncology
·
1
Outcomes of Advanced Renal Cell Carcinoma Patients (Arcc) Treated with Mammalian Target of Rapamycin Inhibitor (Mtori) Therapy Following First-Line Pazopanib (Paz) in a Us Community Oncology Setting
2014
·
T. Hutson
, M.D. Hackshaw
, et al.
·
Annals of Oncology
·
1
Rwd158 Enhancing Oncology Real World Data Quality Through Clinically Relevant Edit Checks in a Large Us Community Oncology Database
2026
·
Debra Rembert
, Christine Spillson
, et al.
·
Value in Health
RWD72 Utilizing NLP to Enhance EHR Data Abstraction Accuracy in Waldenström Macroglobulinemia
2025
·
Alisha Monnette
, Robert Reid
, et al.
·
Value in Health
Descriptive epidemiology of Waldenström macroglobulinemia (WM): Demographics, outcomes, and predictors of survival in the US community oncology setting.
2025
·
Alisha Monnette Kimble
, Nicholas J. Robert
, et al.
·
Journal of Clinical Oncology
PDF
RWD124 Understanding the Value of Chart Abstraction for Assessing Oral Treatment History in the Oncology Outpatient Setting
2023
·
L. Catroppa
, C. Claussen
, et al.
·
Value in Health
PDF
Patient characteristics and survival outcomes associated with early versus delayed molecular testing in metastatic NSCLC.
2014
·
David A. Smith
, Craig H. Reynolds
, et al.
·
Journal of Clinical Oncology
Outcomes of Advanced Renal Cell Carcinoma Patients (Arcc) Treated with First-Line Pazopanib (Paz) in a Us Community Oncology Setting
2014
·
N. Vogelzang
, M.D. Hackshaw
, et al.
·
Annals of Oncology
Treatment ofpatients (pts) with HER2- metastatic breast cancer (MBC) with nab-paclitaxel (nab-P) in the clinical practice setting—Results of a US Oncology survey.
2014
·
Debra A. Patt
, Paula Richardson
, et al.
·
Journal of Clinical Oncology
An analysis of early molecular testing, time to treatment initiation, and medical resource use in metastatic NSCLC.
2014
·
Craig H. Reynolds
, David A. Smith
, et al.
·
Journal of Clinical Oncology
Economic impact of progressive disease (PD) following frontline therapy in classical Hodgkin lymphoma (HL).
2014
·
Christopher A. Yasenchak
, Wan-Yu Tseng
, et al.
·
Journal of Clinical Oncology
Treatment Patterns and Outcomes in Metastatic Colorectal Cancer (MCRC) Patients Treated in a Community Oncology Setting
2014
·
T.H. Cartwright
, I. PAN
, et al.
·
Value in Health
PDF
Show more works
View as search
Works count:
22
Citation count:
210
H-index:
6
I10-index:
6
Year
Topic
Type